RNAC
Cartesian Therapeutics Inc.
8.00$
+2.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 578.1% | 242.8% | 189.3% | 21,818.8% | 5,281.0% | 640.2% | – | – | 1.8% | 6.0% | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.2% | 100.0% | 100.0% | 100.0% | |
| 344.9% | 382.3% | 367.5% | 21,818.8% | 5,281.0% | 640.2% | 328.4% | 80.8% | 65.3% | 274.0% | 115.9% | 2,074.9% | |
| 261.6% | 138.7% | 161.5% | 9,094.7% | 2,019.7% | 245.5% | 114.0% | 24.6% | 21.5% | 155.6% | 77.4% | 1,125.1% | |
| 606.5% | 503.6% | 519.0% | 30,551.2% | 7,192.7% | 885.6% | 442.4% | 105.4% | 85.0% | 432.3% | 212.8% | 3,199.9% | |
| -506.5% | -421.0% | -428.9% | -30,813.5% | -7,200.7% | -785.6% | -342.4% | -5.4% | 13.1% | -332.3% | -112.8% | -3,099.9% | |
| 18.2% | 15.8% | 15.5% | 582.6% | 165.4% | 22.7% | 9.4% | 3.3% | 2.7% | 10.9% | 0.0% | – | |
| -423.7% | -418.8% | -448.0% | -31,556.0% | -7,235.4% | -829.0% | -415.0% | -11.4% | 31.4% | -918.0% | -198.2% | -4,987.3% | |
| 16.7% | 15.3% | 5.6% | 146.9% | 0.0% | 27.8% | 9.9% | 18.8% | -0.5% | -73.1% | 0.7% | -328.7% | |
| -423.7% | -418.8% | -448.0% | -31,556.0% | -7,235.4% | -829.0% | -415.0% | -30.2% | 31.9% | -844.9% | -199.0% | -4,658.6% | |
| -377.1% | -385.7% | -422.6% | -30,611.1% | -6,962.0% | -775.9% | -395.2% | -6.1% | 36.0% | -903.8% | -195.3% | -4,881.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.